Pineridge Advisors’s Mesa Laboratories MLAB Stock Holding History

Pineridge Advisors’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-14	Closed	-$1.47K	–	743
2023 Q4	$1.47K	Buy	+14	New	+$1.36K	﹤0.01%	657

Other funds holding MLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BCM

Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return

Pineridge Advisors's MLAB Position: Q1 2024 in Review

Pineridge Advisors sold out of Mesa Laboratories (MLAB) in Q1 2024, closing a stake of 14 shares — an estimated $1.47K sold.

Pineridge Advisors first reported a position in MLAB in Q4 2023 and held it in 1 quarter. The position peaked at $1.47K in Q4 2023. 155 funds tracked by Wall St. Rank hold MLAB as of Q1 2024.

Pineridge Advisors reported no remaining Mesa Laboratories position as of Q1 2024 after selling out during the quarter.
Pineridge Advisors sold 14 Mesa Laboratories shares in Q1 2024, an estimated $1.47K.
Pineridge Advisors first reported a position in Mesa Laboratories in Q4 2023 and held it in 1 quarter.
Pineridge Advisors's Mesa Laboratories position peaked at $1.47K in Q4 2023.
155 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2024.

Based on Pineridge Advisors's 13F filing for Q1 2024, filed 16 May 2024.